Form 4 for HCAT Health Catalyst, Inc.
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001562180-22-001530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-16 | 2022-02-14 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $10.67 | +14.1K | 155.0K | +10% | +$150.0K |
| DM | 2022-02-16 | 2022-02-14 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $0.00 | -14.1K | 10.8K | -57% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | M | A | 2,009 | $10.72 | 142,935 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-14 | M | A | 12,051 | $10.66 | 154,986 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-14 | M | D | 12,051 | $0.00 | 0 | D | $10.66 · — to 2027-04-27 | 12,051 Common Stock | (F2) 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-02-14 | M | D | 2,009 | $0.00 | 10,764 | D | $10.72 · — to 2027-10-26 | 2,009 Common Stock | (F1) 25% of the 12,773 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 26, 2021. |